English Blogactiv Posts - EU Blog Platform

Archives for Health

HTML clipboardASH 2009: Novartis looks to position Tasigna as an alternative to Gleevec in CML At this year’s American Society of Hematology meeting, researchers presented results from a Phase III study comparing Tasigna and Gleevec in newly diagnosed chronic myeloid leukemia. While Tasigna’s efficacy is impressive, it is unlikely that the drug […]

This year’s American College of Rheumatology Annual Conference in Philadelphia. No ground-breaking data for rheumatoid arthritis therapies were presented; instead, systemic lupus erythematosus stole the limelight. ACR 2009: Benlysta outshines disappointing rheumatoid arthritis data This year’s American College of Rheumatology Annual Conference in Philadelphia. No ground-breaking data for rheumatoid arthritis therapies were […]

EurActiv Network